Dr. Víctor Andrés Arrieta explores how p-ERK activation links to better survival in rGBM patients treated with anti-PD-1 immunotherapy.

#ExpertAnswers: Victor Arrieta on Anti-PD-1 Immunotherapy for Recurrent Glioblastoma

#ExpertAnswers is a podcast by InsideScientific, the online environment for Life Science webinars, virtual events, interviews and educational content that helps you do your best work. On this channel, we will be featuring discussions with experts as they answer some of the best questions from recent webinars. Check out our sister podcast #ShareScience for even more great life science content!

Podcast

#ExpertAnswers: Victor Arrieta on Anti-PD-1 Immunotherapy for Recurrent Glioblastoma

Podcast

About this episode